The immune system and cancer
The immune system protects organisms against foreign pathogens such as bacteria, viruses and fungi as well as an organism’s own cancerous cells.
The immune system is complex and is made up of different organs, cells, and proteins.
The two major components of the human immune system are the innate and adaptive immune systems.
The innate immune system
The innate immune system provides a first immediate response to pathogens. The innate immune system detects so-called PAMPs (Pathogen Associated Molecular Patterns) which are larger structures that do not normally occur in human bodiesbut that are common in/on pathogens. Examples include microbial cell-wall molecules and viral RNA. Upon their detection, the innate immune system activates cells to attack and destroy corresponding cells / virusses. The innate immune system also activates the adaptive immune response. Important cells in the innate immune system include so-called macrophages, neutrophils, dendritic cells, mast cells and basophils as well as natural killer cells. The innate immune system can develop persistent resistance to reinfection, a phenomenon termed trained immunity or innate immune memory.
The adaptive immune system
The adaptive immune system provides a second and tailored response by learning to recognise molecules it has previously encountered. The cells of adaptive immunity include B-cells and T-cells. Both target viruses and/or bacteria on the basis of molecules that differ from those of the host. After a first response, the B- and T-cells that recognised the foreign molecule remain as memory cells and provide a faster and stronger response should the pathogen return. This memory is also the basis for vaccination; the adaptive immune system will quickly recognise a molecule to which it has responded previously. As a result, the adaptive immune system can efficiently & quickly target any recurring infection.
Regulation of the immune system
The immune system targets pathogens but should not attack healthy cells. The immune system therefore comprises all kinds of checks and balances evolved to prevent the immune system from killing an organism’s non-pathogenic cells. These checks and balances are very important; auto-immune diseases can happen if an organism’s immune-system mistakenly does target healthy cells and can be severe and difficult to treat.
The immune system & cancer
Cancers can develop in cells of the immune system; multiple kinds of leukaemia & lymphoma are cancers of the immune system itself.
Otherwise, the immune system is an essential safeguard against cancer. The immune system is known to kill cancerous and pre-cancerous cells and will often prevent cancer growth.
The immune system can specifically target cancer cells since they are genetically and hence phenotypically different and can present new proteins, polysaccharides, lipids and combinations thereof on their cell surface that can be recognised by the immune system.
Natural killer cells, dendritic cells , polymorphonuclear neutrophils, and macrophages are first-line effectors to damaged cells and cancer cells. Natural killer T cells and γδ T cells play roles as both innate and adaptive components, through close interactions with cells of the adaptive immune system.
Not all cancer cells are eliminated by the immune system; cancers continue to evolve and evasion of the immune system is a hallmark of tumours. Ideally therefore, the immune system is able to adapt to such cancer evolution.
- Hopkins Medicine; The Immune System
- Center for Innate Immunity and Immune Disease; What is innate immunity?
- Netea MG, Joosten LA, Latz E, Mills KH, Natoli G, Stunnenberg HG, O'Neill LA, Xavier RJ. Trained immunity: A program of innate immune memory in health and disease. Science. 2016 Apr 22;352(6284).
- Cancer Treatment Centers of America; How does the immune system work? When it comes to cancer, it's complicated
- Hopkins Medicine; What Are Common Symptoms of Autoimmune Disease?
- Society for Immunotherapy for Cancer; Understanding the Immune System
- Liu Y, Zeng G. Cancer and innate immune system interactions: translational potentials for cancer immunotherapy. J Immunother. 2012 May;35(4):299-308.